Un Antibiotico Beta-Lattamico Della Classe Delle Tienamicine Nel Trattamento Delle Uti Complicate

Acar J. F. , Goldstein F. W. , Kitzis M. D. , Gutmann L. : Activity of imipenem on aerobic bacteria. J. Antimicrob. Chemother., 12; Suppl. D., 37 (1983).

Baumgartner J. D. , Glauser M. P. : Comparative study of imipenem in severe infections. J. Antimicrob. Chemother., 12; Suppl. D, 141 (1983).

Guerra J. G. , Casalino E. , Palomino J. C. , Barboza E. , Del Castillo M. , Gonzales Del Riego M. , Huapaya V. , Antunez De Mayolo E. : Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients. Rev. Infect. Dis., 7; Suppl. 3, 463 (1985).

Johnson D. E. , Calia F. M. , Snyder M. J. , Warren J. W. , Schimpff S. C. : Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats. J. Antimicrob. Chemother., 12; Suppl. D, 89 (1983).

Jones R. N. : Review of the in vitro spectrum of activity of Imipenem. Amer. J. Med., 78; Suppl. 6A, 22–32 (1985).

Kropp H. , Gerkens L. , Sundelof G. , Kahan F. M. : Antibacterial activity of imipenem: the first Thienamycin antibiotic. Rev. Infect. Dis., 7; Suppl. 3, 389–410 (1985).

Mitsuhashi S. : In vitro and in vivo antibacterial activity of imipenem against clinical isolates of bacteria. J. Antimicrob. Chemother., 12; Suppl. D, 53 (1983).

Neu H. C. , Labthavikul P. : Comparative in vitro activity of N-formimidoylthienamycin against Gram positive and Gram negative aerobic and anaerobic species and its beta-lactamase stability. Antimicrob. Agents Chemother., 21; 180 (1982).

Neu H. C. : Clinical perspectives on imipenem. J. Antimicrob. Chemother., 12; Suppl. D, 149 (1983).

Norby S. R. : Imipenem/cilastatin: rationale for a fixed combination. Rev. Infect. Dis., 7; Suppl. 3, 447 (1985).

Sawai T. , Tsukamoto K. : Cefoxitin, N-formimidoyl thienamycin, clavulanic acid and penicillanic acid sulfone as suicide inhibitors for different types of β-lactamases produced by Gram-negative bacteria. J. Antibiot. (Tokyo), 35; 1594–1602 (1982).

Scheid W. M. , Kelley J. M. : Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis. J. Antimicrob. Chemother., 12; Suppl. D, 65 (1983).

Wexler H. M. , Finegold S. M. : In vitro activity of imipenem against anaerobic bacteria. Rev. Infect. Dis., 7; Suppl. 3, 417 (1985).